Skip to main content
SpringerLink
Log in

AI for drug discovery is booming, but who owns the patents?

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Biopharma companies debate whether to patent their algorithms for finding medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. New York, NY, USA

    Matthew Hutson

Authors
  1. Matthew Hutson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hutson, M. AI for drug discovery is booming, but who owns the patents?. Nat Biotechnol 41, 1494–1496 (2023). https://doi.org/10.1038/s41587-023-02029-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-023-02029-7

  • Springer Nature America, Inc.

Search

Navigation